US Stock MarketDetailed Quotes

PRTG Portage Biotech

Watchlist
  • 5.400
  • -0.750-12.20%
Trading Oct 2 15:25 ET
5.66MMarket Cap-74P/E (TTM)

Portage Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.17%-1.69M
-18.42%-14.3M
33.33%-3.12M
-26.89%-3.43M
-70.86%-4.29M
-58.69%-3.45M
-78.49%-12.07M
-107.95%-4.68M
-63.09%-2.7M
-97.02%-2.51M
Net income from continuing operations
71.92%-1.66M
27.98%-75.38M
73.62%-24.91M
-424.97%-39.38M
-376.04%-5.17M
-264.68%-5.93M
-446.02%-104.67M
-965.72%-94.46M
-78.34%-7.5M
62.29%-1.09M
Operating gains losses
-2,384.00%-1.14M
-3,568.08%-7.39M
-94,528.57%-6.62M
-912.38%-853K
-28.57%40K
-15.25%50K
126.96%213K
98.36%-7K
229.63%105K
30.23%56K
Depreciation and amortization
-27.27%8K
5,300.00%54K
--13K
1,400.00%15K
--15K
--11K
--1K
--0
--1K
--0
Deferred tax
--0
40.92%-10.56M
--0
-536.83%-9.5M
64.16%-915K
94.20%-148K
-506.94%-17.88M
-409.03%-14.95M
2,264.13%2.18M
-288.58%-2.55M
Other non cash items
----
-182.59%-7.32M
-121.26%-6.88M
-425.19%-1.72M
432.50%133K
3,703.33%1.14M
-2,259.17%-2.59M
-10,463.33%-3.11M
1,660.00%528K
-233.33%-40K
Change In working capital
48.92%968K
9,920.00%982K
77.74%-313K
-127.35%-212K
845.22%857K
-11.68%650K
97.83%-10K
-164.29%-1.41M
96.70%775K
-387.50%-115K
-Change in receivables
----
----
----
-106.25%-4K
----
----
----
----
-84.98%64K
-97.13%5K
-Change in prepaid assets
1,297.01%802K
97.40%-32K
60.36%-348K
165.86%218K
-57.14%165K
83.58%-67K
-240.48%-1.23M
-114.67%-878K
-177.34%-331K
-17.03%385K
-Change in payables and accrued expense
-82.37%128K
-12.75%972K
131.96%178K
-143.17%-430K
197.08%498K
-38.89%726K
191.91%1.11M
-303.28%-557K
387.86%996K
13.93%-513K
-Change in other current assets
480.00%38K
66.67%40K
--39K
-83.33%4K
--7K
---10K
114.55%24K
--0
116.90%24K
--0
-Change in other working capital
----
-97.62%2K
----
----
----
--1K
115.38%84K
500.00%54K
-21.43%22K
----
Cash from discontinued investing activities
Operating cash flow
51.17%-1.69M
-18.42%-14.3M
33.33%-3.12M
-26.89%-3.43M
-70.86%-4.29M
-58.69%-3.45M
-78.49%-12.07M
-107.95%-4.68M
-63.09%-2.7M
-97.02%-2.51M
Investing cash flow
Cash flow from continuing investing activities
555.75%2.81M
2.81M
0
-617K
0
0
Net PPE purchase and sale
----
--0
--0
--0
----
----
---3K
--0
--0
----
Net investment purchase and sale
----
--2.81M
----
----
----
----
--0
----
----
----
Net other investing changes
----
----
----
----
----
----
---614K
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
555.75%2.81M
--2.81M
--0
----
----
---617K
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
-101.32%-8K
5,200.85%5.97M
-100.19%-4K
591.82%5.33M
101.30%39K
606K
-100.43%-117K
2.12M
770K
-3,614.81%-3.01M
Net issuance payments of debt
-28.57%-9K
98.00%-40K
---12K
---11K
99.50%-10K
---7K
---2M
--0
--0
---2M
Net common stock issuance
--0
102.15%6.03M
144.33%5.35M
--0
--50K
--632K
-89.75%2.98M
--2.19M
--794K
--0
Proceeds from stock option exercised by employees
--1K
--0
----
----
----
--0
--0
----
----
----
Net other financing activities
----
98.18%-20K
-7,987.88%-5.34M
22,341.67%5.34M
---1K
---19K
40.66%-1.1M
---66K
---24K
----
Cash from discontinued financing activities
Financing cash flow
-101.32%-8K
5,200.85%5.97M
-100.19%-4K
591.82%5.33M
101.30%39K
--606K
-100.43%-117K
--2.12M
--770K
-3,614.81%-3.01M
Net cash flow
Beginning cash position
-52.32%5.03M
-54.84%10.55M
-59.24%5.34M
-77.09%3.45M
-63.65%7.7M
-54.84%10.55M
743.03%23.35M
-48.82%13.1M
-44.84%15.04M
-26.00%21.18M
Current changes in cash
40.50%-1.69M
56.92%-5.52M
87.77%-313K
198.04%1.9M
30.71%-4.25M
-30.84%-2.85M
-162.22%-12.81M
-13.68%-2.56M
-16.65%-1.93M
-352.65%-6.14M
End cash Position
-56.69%3.33M
-52.32%5.03M
-52.32%5.03M
-59.24%5.34M
-77.09%3.45M
-63.65%7.7M
-54.84%10.55M
-54.84%10.55M
-48.82%13.1M
-44.84%15.04M
Free cash flow
51.17%-1.69M
-18.39%-14.3M
33.33%-3.12M
-26.89%-3.43M
-70.66%-4.29M
-58.69%-3.45M
-78.53%-12.08M
-107.95%-4.68M
-63.09%-2.7M
-97.25%-2.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.17%-1.69M-18.42%-14.3M33.33%-3.12M-26.89%-3.43M-70.86%-4.29M-58.69%-3.45M-78.49%-12.07M-107.95%-4.68M-63.09%-2.7M-97.02%-2.51M
Net income from continuing operations 71.92%-1.66M27.98%-75.38M73.62%-24.91M-424.97%-39.38M-376.04%-5.17M-264.68%-5.93M-446.02%-104.67M-965.72%-94.46M-78.34%-7.5M62.29%-1.09M
Operating gains losses -2,384.00%-1.14M-3,568.08%-7.39M-94,528.57%-6.62M-912.38%-853K-28.57%40K-15.25%50K126.96%213K98.36%-7K229.63%105K30.23%56K
Depreciation and amortization -27.27%8K5,300.00%54K--13K1,400.00%15K--15K--11K--1K--0--1K--0
Deferred tax --040.92%-10.56M--0-536.83%-9.5M64.16%-915K94.20%-148K-506.94%-17.88M-409.03%-14.95M2,264.13%2.18M-288.58%-2.55M
Other non cash items -----182.59%-7.32M-121.26%-6.88M-425.19%-1.72M432.50%133K3,703.33%1.14M-2,259.17%-2.59M-10,463.33%-3.11M1,660.00%528K-233.33%-40K
Change In working capital 48.92%968K9,920.00%982K77.74%-313K-127.35%-212K845.22%857K-11.68%650K97.83%-10K-164.29%-1.41M96.70%775K-387.50%-115K
-Change in receivables -------------106.25%-4K-----------------84.98%64K-97.13%5K
-Change in prepaid assets 1,297.01%802K97.40%-32K60.36%-348K165.86%218K-57.14%165K83.58%-67K-240.48%-1.23M-114.67%-878K-177.34%-331K-17.03%385K
-Change in payables and accrued expense -82.37%128K-12.75%972K131.96%178K-143.17%-430K197.08%498K-38.89%726K191.91%1.11M-303.28%-557K387.86%996K13.93%-513K
-Change in other current assets 480.00%38K66.67%40K--39K-83.33%4K--7K---10K114.55%24K--0116.90%24K--0
-Change in other working capital -----97.62%2K--------------1K115.38%84K500.00%54K-21.43%22K----
Cash from discontinued investing activities
Operating cash flow 51.17%-1.69M-18.42%-14.3M33.33%-3.12M-26.89%-3.43M-70.86%-4.29M-58.69%-3.45M-78.49%-12.07M-107.95%-4.68M-63.09%-2.7M-97.02%-2.51M
Investing cash flow
Cash flow from continuing investing activities 555.75%2.81M2.81M0-617K00
Net PPE purchase and sale ------0--0--0-----------3K--0--0----
Net investment purchase and sale ------2.81M------------------0------------
Net other investing changes ---------------------------614K--0--0----
Cash from discontinued investing activities
Investing cash flow ----555.75%2.81M--2.81M--0-----------617K--0--0----
Financing cash flow
Cash flow from continuing financing activities -101.32%-8K5,200.85%5.97M-100.19%-4K591.82%5.33M101.30%39K606K-100.43%-117K2.12M770K-3,614.81%-3.01M
Net issuance payments of debt -28.57%-9K98.00%-40K---12K---11K99.50%-10K---7K---2M--0--0---2M
Net common stock issuance --0102.15%6.03M144.33%5.35M--0--50K--632K-89.75%2.98M--2.19M--794K--0
Proceeds from stock option exercised by employees --1K--0--------------0--0------------
Net other financing activities ----98.18%-20K-7,987.88%-5.34M22,341.67%5.34M---1K---19K40.66%-1.1M---66K---24K----
Cash from discontinued financing activities
Financing cash flow -101.32%-8K5,200.85%5.97M-100.19%-4K591.82%5.33M101.30%39K--606K-100.43%-117K--2.12M--770K-3,614.81%-3.01M
Net cash flow
Beginning cash position -52.32%5.03M-54.84%10.55M-59.24%5.34M-77.09%3.45M-63.65%7.7M-54.84%10.55M743.03%23.35M-48.82%13.1M-44.84%15.04M-26.00%21.18M
Current changes in cash 40.50%-1.69M56.92%-5.52M87.77%-313K198.04%1.9M30.71%-4.25M-30.84%-2.85M-162.22%-12.81M-13.68%-2.56M-16.65%-1.93M-352.65%-6.14M
End cash Position -56.69%3.33M-52.32%5.03M-52.32%5.03M-59.24%5.34M-77.09%3.45M-63.65%7.7M-54.84%10.55M-54.84%10.55M-48.82%13.1M-44.84%15.04M
Free cash flow 51.17%-1.69M-18.39%-14.3M33.33%-3.12M-26.89%-3.43M-70.66%-4.29M-58.69%-3.45M-78.53%-12.08M-107.95%-4.68M-63.09%-2.7M-97.25%-2.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data